INO Stock Analysis: Buy, Sell, or Hold?
INO - Inovio Pharmaceuticals, Inc.
$1.30
-0.06 (-4.41%)
▼
5d:
-10.96%
30d:
+12.07%
90d:
-19.25%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
INO is down 11.0% this week, but smart money is accumulating calls. Top strike: $2 2026-06-18 with 19,408 OI. Call ratio: 98% View Scanner →
Strength: 10.0/10
Get Alerted When INO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
17 traders called INO this week
87% bullish • 4 bearish
87% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: INO is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: INO is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: INO is currently trading at $1.30, which is considered slightly high relative to its 30-day fair value range of $1.07 to $1.31.
Technical Outlook: Technically, INO is in a downtrend. Immediate support is located at $1.10, while resistance sits at $1.79. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: INO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.96 (+358.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INO is in a downtrend. Immediate support is located at $1.10, while resistance sits at $1.79. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: INO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.96 (+358.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.07 -
$1.31
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 358.5% below Wall St target ($5.96)
- WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.07 -
$1.31
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.79
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.24
Wall Street Target
$5.96
(+358.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: May 18, 2026 8:18 AM ET
Data refreshes hourly during market hours. Next update: 9:18 AM
Data refreshes hourly during market hours. Next update: 9:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
